Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	32.74	456.01	-343.54
Graham Fair Price	-28.81	3.78	5.30
PEG	24.32	3.67	2.96
Price/Book	-12.58	9.32	10.66
Price/Cash Flow	-1.41	262.73	266.49
Prices/Earnings	-37.19	-159.27	-116.09
Price/Sales	-23.96	18.25	24.00
Price/FCF	-1.41	262.73	266.49
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.66	0.53	0.53
Operating Margin	-2.84	-0.08	-0.08
ROA	54.26	< 0.005	< 0.005
ROE	-0.02	-0.01	36.28
ROIC	-0.01	-0.01	4.51
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.52	< 0.005	23743.05
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.28	-0.06	-77.42
EPS QOQ	0.39	0.43	10.35
FCF QOQ	-0.32	-0.20	35.69
Revenue QOQ	0.04	0.03	-14.59
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	< 0.005	< 0.005	-3.93
Days Sales Outstanding (DSO)	38.22	37.82	-1.05
Inventory Turnover	112493000.00	117100000.00	4.10
Debt/Capitalization	0.58	0.71	21.29
Quick Ratio	4.97	6.47	30.02
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.38	6.58	-10.81
Cash	10.01	14.74	47.22
Capex	-0.21	-0.21	-0.45
Free Cash Flow	0.30	0.23	-20.92
Revenue	3.28	3.36	2.53
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	5.16	6.66	29.12
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-34.99	80.68	130.59
Naive Interpretation	Member

06 - Financial Health · Bad

Rating